do glp 1 help with high cholesterol GLP-1 Agonists in Cardiovascular Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies Does Semaglutide Lower Cholesterol? Research

The large-scale SELECT trial demonstrated that semaglutide reduced major adverse cardiovascular events by 20% 13

Recent clinical wins include: Taltz + Zepbound combination: Delivered superior efficacy in adults with psoriatic arthritis and obesity Orforglipron: Helped patients maintain weight loss after switching from injectables to oral therapy a potentially massive market expansion Retatrutide: The companys triple agonist delivered average weight loss of 71.2 pounds along with substantial osteoarthritis pain relief The orforglipron data matters particularly for the competitive landscape

Every section below builds on this foundation

Why Tirzepatide May Lead to Greater Weight Loss The data isn't subtle